Cargando…

Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia

The last decade has seen great strides in the field of cancer immunotherapy, especially the treatment of melanoma. Beginning with the identification of cancer antigens, followed by the clinical application of anti-cancer peptide vaccination, it has now been proven that adoptive T-cell therapy (ACT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochi, Toshiki, Fujiwara, Hiroshi, Yasukawa, Masaki
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864513/ https://www.ncbi.nlm.nih.gov/pubmed/20454585 http://dx.doi.org/10.1155/2010/521248

Ejemplares similares

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
por: Fujiwara, Hiroshi
Publicado: (2014)

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy
por: Casey, Nicholas Paul, et al.
Publicado: (2016)

Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Nagai, K, et al.
Publicado: (2011)

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor
por: Asai, Hiroaki, et al.
Publicado: (2013)

Human herpesvirus 6 infection impairs Toll-like receptor signaling
por: Murakami, Yuichi, et al.
Publicado: (2010)

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
por: Maruta, Masaki, et al.
Publicado: (2019)

Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
por: Fan, Mingxue, et al.
Publicado: (2017)

A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications
por: Palianina, Darya, et al.
Publicado: (2023)

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
por: Ochi, Toshiki, et al.
Publicado: (2021)

HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer
por: Foley, Kendra C., et al.
Publicado: (2017)

Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia
por: Sohn, Hyun-Jung, et al.
Publicado: (2017)

Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells
por: Robbins, Paul F., et al.
Publicado: (2013)

Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression
por: Dötsch, Sarah, et al.
Publicado: (2023)

CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
por: Effern, Maike, et al.
Publicado: (2022)

Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer
por: Brusko, Todd M., et al.
Publicado: (2010)

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016)

Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice
por: Liu, X, et al.
Publicado: (2016)

Improving the outcome of adoptive cell transfer by targeting tumor escape
por: Kaluza, Karen M., et al.
Publicado: (2013)

Adoptive T-cell therapy for Leukemia
por: Garber, Haven R, et al.
Publicado: (2014)

Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling
por: Matisz, C. E., et al.
Publicado: (2017)

Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
por: Chruściel, Elżbieta, et al.
Publicado: (2020)

NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells
por: Zhuang, Xiaoxuan, et al.
Publicado: (2022)

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy
por: Monzavi, Seyed Mostafa, et al.
Publicado: (2023)

Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors
por: Adu-Berchie, Kwasi, et al.
Publicado: (2023)

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
por: Fujiwara, Yuki, et al.
Publicado: (2022)

Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer
por: Heemskerk, Mirjam H.M., et al.
Publicado: (2004)

A transfer-learning approach to predict antigen immunogenicity and T-cell receptor specificity
por: Bravi, Barbara, et al.
Publicado: (2023)

Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung Injury
por: Kustermann, Monika, et al.
Publicado: (2022)

Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer
por: Lee, Hee Jin, et al.
Publicado: (2017)

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
por: Oflazoglu, Ezogelin, et al.
Publicado: (2007)

Anti-telomerase T cells adoptive transfer
por: De Sanctis, Francesco, et al.
Publicado: (2017)

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
por: Godet, Yann, et al.
Publicado: (2008)

Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
por: Hegde, Meenakshi, et al.
Publicado: (2013)

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8(+) T cells
por: Gattinoni, Luca, et al.
Publicado: (2005)

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
por: Supimon, Kamonlapat, et al.
Publicado: (2021)

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
por: Lu, Dan, et al.
Publicado: (2023)

Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting
por: Sanz-Ortega, Laura, et al.
Publicado: (2020)

B cells imprint adoptively transferred CD8(+) T cells with enhanced tumor immunity
por: Smith, Aubrey S, et al.
Publicado: (2022)

Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
por: Lloyd, Angharad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8fqbaonufld1tarri3r30tnae9